mifepristone has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baches, S; Krugers, HJ; Lesuis, SL; Lucassen, PJ; Weggen, S | 1 |
| Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J | 1 |
| Belanoff, JK; Canet, G; Chevallier, N; Desrumaux, C; Givalois, L; Hunt, H; Ollivier, M; Pineau, F | 1 |
1 review(s) available for mifepristone and Cognitive Decline
| Article | Year |
|---|---|
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia | 2018 |
2 other study(ies) available for mifepristone and Cognitive Decline
| Article | Year |
|---|---|
Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice.
Topics: Age Factors; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Behavior, Animal; Cognitive Dysfunction; Corticosterone; Disease Models, Animal; Female; Hippocampus; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Peptide Fragments; Receptors, Glucocorticoid; Stress, Psychological | 2018 |
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aza Compounds; Cognitive Dysfunction; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Heterocyclic Compounds, 4 or More Rings; Hippocampus; Hypothalamo-Hypophyseal System; Isoquinolines; Male; Mifepristone; Molecular Targeted Therapy; Pituitary-Adrenal System; Pyrazoles; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2016 |